FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE Share Price

Certificat

DE000JK53618

Real-time Bid/Ask 13:48:59 27/06/2024 BST
0.27 EUR / 0.34 EUR +17.31% Intraday chart for FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE
Current month-99.06%
1 month-98.65%
Date Price Change
27/06/24 0.28 +7.69%
26/06/24 0.26 +4.00%
25/06/24 0.25 -41.86%
24/06/24 0.43 -43.42%
21/06/24 0.76 +4.11%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 11:44 am

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying TANDEM DIABETES CARE, INC.
Issuer J.P. Morgan
WKN JK5361
ISINDE000JK53618
Date issued 27/03/2024
Strike 36.59 $
Maturity Unlimited
Parity 16 : 1
Emission price 10.07
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 27.76
Lowest since issue 0.24
Spread 0.07
Spread %20.59%

Company Profile

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Sector
-
More about the company

Ratings for Tandem Diabetes Care, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Tandem Diabetes Care, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
40.64 USD
Average target price
49.93 USD
Spread / Average Target
+22.87%
Consensus